Open access
Aug 2026
Effectiveness of Omicron JN.1 vaccination against infection with JN.1-derived SARS-CoV-2 subvariants in a prospective cohort study in the Netherlands.
It was found that, during a 5-month study period with low incidence, JN.1-vaccination provided limited added protection in preventing SARS-CoV-2 infection.
Anne J. Huiberts, D. Eggink, B. de Gier et al.
· Vaccine · 0 citations